Polymicrobial vaginal biofilm matrix (PVBM)

The polymicrobial vaginal biofilm matrix is a complex, structured community of microorganisms, predominantly Gardnerella vaginalis, encased within a self-produced extracellular polymeric substance (EPS) consisting of polysaccharides, proteins, and extracellular DNA (Swidsinski et al., 2005, American Journal of Obstetrics and Gynecology). This matrix serves as a physical and chemical barrier that protects pathogenic bacteria from the host immune system and significantly increases resistance to standard antibiotic treatments like metronidazole. In the context of bacterial vaginosis (BV), the biofilm adheres tenaciously to the vaginal epithelium, forming characteristic 'clue cells' and facilitating the persistence of anaerobic pathogens (Machado et al., 2015, Frontiers in Microbiology). Therapeutic strategies targeting the matrix aim to degrade its structural components or alter the local microenvironment to restore a healthy, Lactobacillus-dominant microbiome. Effective disruption of this biofilm is considered essential for preventing the high rates of recurrence associated with traditional BV therapies (Marrazzo et al., 2019, Clinical Infectious Diseases). Understanding the composition and dynamics of this matrix is a primary focus for developing next-generation treatments for chronic vaginal infections.

Other names

Bacterial vaginosis biofilmVaginal extracellular polymeric substance matrixGardnerella-dominant biofilmVaginal EPS matrix

Disruption of the extracellular polymeric substance (EPS) matrix through acidification, chelation of divalent cations (e.g., calcium and magnesium), or enzymatic degradation of extracellular DNA (eDNA) and proteins to enhance antibiotic penetration and facilitate microbial clearance (Muzny et al., 2019, The Journal of Infectious Diseases; Machado et al., 2015, Frontiers in Microbiology).